Works matching DE "PATHOLOGIC complete response"


Results: 425
    1
    2

    Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1619, doi. 10.3390/cancers17101619
    By:
    • Di Leone, Alba;
    • Franco, Antonio;
    • Castagnetta, Virginia;
    • Silenzi, Marta;
    • Accetta, Cristina;
    • Carnassale, Beatrice;
    • D'Archi, Sabatino;
    • De Lauretis, Flavia;
    • Di Guglielmo, Enrico;
    • Gagliardi, Federica;
    • Magno, Stefano;
    • Moschella, Francesca;
    • Natale, Maria;
    • Sanchez, Alejandro Martin;
    • Scardina, Lorenzo;
    • Masetti, Riccardo;
    • Franceschini, Gianluca
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Development and validation of a gene expression-based Breast Cancer Purity Score.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00730-7
    By:
    • Barreca, Marco;
    • Dugo, Matteo;
    • Galbardi, Barbara;
    • Győrffy, Balázs;
    • Gianni, Luca;
    • Bisagni, Giancarlo;
    • Colleoni, Marco;
    • Del Mastro, Lucia;
    • Zamagni, Claudio;
    • Mansutti, Mauro;
    • Zambetti, Milvia;
    • Frassoldati, Antonio;
    • Montemurro, Filippo;
    • Bengala, Carmelo;
    • Mariani, Gabriella;
    • Gambaro, Anna;
    • Zambelli, Stefania;
    • Bianchini, Giampaolo;
    • Russo, Stefania;
    • Huang, Chiun-Sheng
    Publication type:
    Article
    13

    A phenocopy signature of TP53 loss predicts response to chemotherapy.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00722-7
    By:
    • Bakhtiar, Hamza;
    • Sharifi, Marina N.;
    • Helzer, Kyle T.;
    • Shi, Yue;
    • Bootsma, Matthew L.;
    • Shang, Tianfu A.;
    • Chrostek, Matthew R.;
    • Berg, Tracy J.;
    • Carson Callahan, S.;
    • Carreno, Viridiana;
    • Blitzer, Grace C.;
    • West, Malinda T.;
    • O'Regan, Ruth M.;
    • Wisinski, Kari B.;
    • Sjöström, Martin;
    • Zhao, Shuang G.
    Publication type:
    Article
    14
    15

    Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 6, p. e2417625, doi. 10.1001/jamanetworkopen.2024.17625
    By:
    • Stoop, Thomas F.;
    • Oba, Atsushi;
    • Wu, Y. H. Andrew;
    • Beaty, Laurel E.;
    • Colborn, Kathryn L.;
    • Janssen, Boris V.;
    • Al-Musawi, Mohammed H.;
    • Franco, Salvador Rodriguez;
    • Sugawara, Toshitaka;
    • Franklin, Oskar;
    • Jain, Ajay;
    • Saiura, Akio;
    • Sauvanet, Alain;
    • Coppola, Alessandro;
    • Javed, Ammar A.;
    • Groot Koerkamp, Bas;
    • Miller, Braden N.;
    • Mack, Claudia E.;
    • Hashimoto, Daisuke;
    • Caputo, Damiano
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-024-01946-y
    By:
    • Dent, Rebecca;
    • Cortés, Javier;
    • Park, Yeon Hee;
    • Muñoz-Couselo, Eva;
    • Kim, Sung-Bae;
    • Sohn, Joohyuk;
    • Im, Seock-Ah;
    • Holgado, Esther;
    • Foukakis, Theodoros;
    • Kümmel, Sherko;
    • Yearley, Jennifer;
    • Wang, Anran;
    • Nebozhyn, Michael;
    • Huang, Lingkang;
    • Cristescu, Razvan;
    • Jelinic, Petar;
    • Karantza, Vassiliki;
    • Schmid, Peter
    Publication type:
    Article
    42
    43

    Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance).

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01963-5
    By:
    • Marks, Jeffrey R.;
    • Zhang, Dadong;
    • Hardman, Timothy;
    • Chen, Yunn-yi;
    • Hall, Allison;
    • Simpson, Lunden;
    • Hieken, Tina;
    • Bedrosian, Isabelle;
    • Price, Elissa;
    • Sheng, Jeff;
    • Dai, Yanwan;
    • Lee, Marissa;
    • Sibley, Alexander B.;
    • Owzar, Kouros;
    • Hwang, E. Shelley
    Publication type:
    Article
    44
    45
    46
    47

    A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 6, p. N.PAG, doi. 10.1016/j.clgc.2024.102222
    By:
    • Liveringhouse, Casey;
    • Sim, Austin J.;
    • Zhang, Jingsong;
    • Jain, Rohit K.;
    • Naidu, Shreyas U.;
    • Linkowski, Lauren;
    • Zemp, Logan W.;
    • Yu, Alice;
    • Sexton, Wade J.;
    • Spiess, Philippe E.;
    • Gilbert, Scott M.;
    • Poch, Michael A.;
    • Pow-Sang, Julio;
    • Li, Roger;
    • Manley, Brandon J.;
    • Vosoughi, Aram;
    • Dhillon, Jasreman;
    • Xu, Hongzhi;
    • Torres-Roca, Javier F.;
    • Johnstone, Peter A.S.
    Publication type:
    Article
    48

    Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102143
    By:
    • Skelton IV, William Paul;
    • Masur, Jack;
    • Thomas, Jonathan;
    • Fallah, Parvaneh;
    • Jain, Rohit K.;
    • Ravi, Praful;
    • Mantia, Charlene;
    • McGregor, Bradley Alexander;
    • Nuzzo, Pier Vitale;
    • Adib, Elio;
    • Zarif, Talal El;
    • Preston, Mark A.;
    • Clinton, Timothy Nguyen;
    • Li, Roger;
    • Steele, Graeme S.;
    • Kassouf, Wassim;
    • Freeman, Dory;
    • Pond, Gregory Russell;
    • Jain, Rakesh K.;
    • Sonpavde, Guru P.
    Publication type:
    Article
    49
    50